Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters and insulin resistance in women with obesity

Metabolism: Clinical and Experimental

Volumn 60, Issue 2, 2011, Pages 272-276

  De Luis, Daniel Antonio ^a   González Sagrado, Manuel ^a   Aller, Rocio ^a   Izaola, Olatz ^a   Conde, Rosa ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CANNABINOID RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CALORIMETRY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMPEDANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MUTANT; NUTRITION; OBESITY; PRIORITY JOURNAL; RECEPTOR GENE; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ADIPOKINES; ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTOR, CANNABINOID, CB1; TRIGLYCERIDES;

EID: 78751645595     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.01.028     Document Type: Article

References (29)

1. Matsuzawa Y. Adipocytokines: emerging therapeutic targets Curr Atheroscler Rep 7 2005 58 62
2. Ameri A. The effects of cannabinoids on the brain Prog Neurobiol 58 1999 315 348
3. Brown S.M., Warger- Miller J., and Mackie K. Cloning and molecular characterization of the rat CB2 cannabinoid receptor Biochim Biophys Acta 1576 2002 255 264
4. Fride E. Endocannabinoids in the central nervous system: an overview Prostaglandins Leukot Essent Fatty Acids 66 2002 221 233
5. Felder C.C., and Glass M. Cannabinoid receptors and their endogenous agonists Ann Rev Pharmacol Toxicol 38 1998 179 200
6. Ravinet T.C., Delgorge C., Menet C., Arnone M., and Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity Int J Obes Relat Metab Disord 28 2004 640 648
7. Gadzicki D., Muller-Vahl K., and Stuhrmann M. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene Mol Cell Probes 13 1999 321 323
8. Duart M.J., Arroyo C.O., and Moreno J.L. Validation of a insulin model for the reactions in RIA Clin Chem Lab Med 40 2002 1161 1167
9. Mathews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., and Treacher D.F. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 414
10. Pfutzner A., Langefeld M., Kunt T., and Lobig M. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance Clin Lab 49 2003 571 576
11. Meier U., and Gressner M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin Clinical Chemstry 50 2004 1511 1525
12. Suominen P. Evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations Clin Chem 50 2004 219 221
13. Lubrano V., Cocci F., Battaglia D., and Papa A. Usefulness of high-sensitivity IL6 measurement for clinical characterization of patients with coronary artery disease J Clin Lab Anal 19 2005 110 114
14. Khan S.S., Smith M.S., reda D., Suffredini A.F., and Mc Coy J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufactures Cytometry B Clin Cytom 61 2004 35 39
15. Feurer I.D., and Mullen J.L. Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry Nutr Clin Pract 1 1986 43 49
16. Pichard C., Slosman D., Hirschel B., and Kyle U. Bioimpedance analysis: an improved method for nutritional follow up Clin Res 41 1993 53
17. Mataix J., and Mañas M. Tablas de composición de alimentos españoles 2003 University of Granada Granada, Spain
18. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., and Jarai Z. Leptin-regulated endocannabinoids are involved in maintaining food intake Nature 410 2001 822 825
19. Engeli S., Jana B., Mareike F., Kerstin G., Jürgen J., and Sandor B. Activation of the peripheral endocannabinoid system in human obesity Diabetes 54 2005 2838 2843
20. Gazzerro P., Caruso M.G., Notarnicola M., Misciagna G., Guerra V., and Laezza C. Association between cannabinoid type 1 receptor polymorphism and body mass index in a southern Italian population Int J Obes 31 2007 908 912
21. Aberle J., Flitsch J., Alessia N., Mann O., Busch P., and Peitsmeier P. Genetic variation may influence obesity only under conditions of diet: analysis of three candidate genes Mol Genet Metab 95 2008 188 191
22. Jaeger J., Mattevi V., Callegari-Jacques S.D., and Hutz M.H. Cannabinoid type 1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population Dis Markers 25 2008 67 74
23. Russo P., Strazzullo P., Cappuccio F., Tregouet D., Lauria F., and Loguercio M. Genetic variations at the endocannabinoid type 1 receptor gene (CRN1) are associated with obesity phenotypes in Men J Clin Endocrinol Metab 92 2007 2382 2389
24. Peeters A., Beckers S., Mertens I., Van Hul W., and Van Gaal L. The G1422A variant of the endocannabinoid receptor gene is associated with abdominal adiposity in obese men Endocrinology 31 2007 138 141
25. Benzinou M., Chevre J.C., Ward K., Lecoeur C., Dina C., and Lobbens S. Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index European population Hum Mol Genet 17 2008 1916 1921
26. Jbilo O., Ravinet-Trillou C., Arnone M., Buisson I., Bribes E., and Peleraux A. The CB1 receptor antagonist rimonabant reverses the diet induced obesity phenotype through the regulation of lipolysis and energy balance FASEB J 19 2005 1567 1569
27. Bensaid M., Gary Bobo M., Esclangron A., Maffrand J.P., Le Fut G., and Oury DOnat F. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp 30 mRNA expression in adipose tissue of obese fa/fa rats and in cultures adipocyte cells Mol Pharmacol 63 2003 908 914
28. Poirier B., Bidoauard J.P., Cadrouvele C., Marniquet X., Staels B., and O'Connor S.E. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile Diabetes Obes Metab 7 2005 65 72
29. Baye T.M., Zhang Y., Smith E., Hillard C.J., Gunnell J., and Myklebust J. Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index Pharmacogenomics 9 2008 1647 1656